Page last updated: 2024-12-07

4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol: tobacco-specific N-nitrosamine; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID105067
SCHEMBL ID1086424
MeSH IDM0146733

Synonyms (21)

Synonym
ccris 6652
3-pyridinebutanol, delta-(methylnitrosoamino)-
4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol
delta-(methylnitrosoamino)-3-pyridinebutanol
brn 0400798
4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol
59578-66-4
iso-nnal
n-(4-hydroxy-1-pyridin-3-ylbutyl)-n-methylnitrous amide
FT-0672053
5-22-14-00730 (beilstein handbook reference)
7m56wxk8nc ,
unii-7m56wxk8nc
4-(n-methyl-n-nitrosamino)-4-(3-pyridyl)butane-1-ol
SCHEMBL1086424
3-pyridinebutanol, .delta.-(methylnitrosoamino)-
.delta.-(methylnitrosoamino)-3-pyridinebutanol
AKOS030255785
DTXSID30920505
FT-0672054
Q27268552

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Using an identical dosing regimen, parallel results were observed in the effects of these isothiocyanates on O6-methylguanine formation in the lung, in which PEITC at either dose resulted in considerable inhibition at 2 or 6 h after NNK administration, while BITC or PITC had little effect."( Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.
Amin, SG; Chung, FL; Hecht, SS; Morse, MA, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.38)18.7374
1990's23 (71.88)18.2507
2000's6 (18.75)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.63 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]